AGP Picks
View all

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on August 6, 2026

Domestic Metals to Commence Drill Program at Smart Creek Project, Montana
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
HPQ ENDURA+ GEN4 21700 Cells Achieve UN 38.3 Certification Supports Ongoing Customer Qualification Activities
Les cellules HPQ ENDURA+ GEN4 21700 obtiennent la certification UN 38.3; les activités de qualification auprès des clients progressent
Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results
Martin Eade and Natalie Southgate Launch Still Not Dead Podcast, Reaching the Top 10% of New Podcasts Globally Within Its First Week
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Safe Pro Group Receives $780,000 Purchase Order for Department of War Package of Edge AI-Powered Threat Mapping and Blue UAS Drones
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Gilat Demonstrates Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links
Immunocore reports second quarter financial results and provides a business update
Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialization of medtech portfolio
Power Apps Project Stalled or Abandoned: What Actually Fixes It
What Is Physical AI, and How Do Autonomous Robots Work in Factories?
Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.